| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.33 | 0.06 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.3 | 0.09 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.29 | 0.09 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.24 | 0.06 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.2 | 0.0004 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.19 | 0.2 |